Resources

 

Medscape CME

 
 

Featured CME

 
  • CME FDA Safety Changes: Advair Diskus and Vfend The FDA has approved revisions to the safety labeling for fluticasone propionate plus salmeterol xinafoate inhalation powder and voriconazole tablets, injection, and oral suspension.
 

News CME

 
 
 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.